Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

  • US 8,629,173 B2
  • Filed: 11/18/2011
  • Issued: 01/14/2014
  • Est. Priority Date: 03/20/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating psoriasis, which comprises orally administering to a patient having psoriasis about 20 mg twice daily of an unsolvated crystal form of the compound of Formula (I):

View all claims

    Thank you for your feedback